Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Joseph Beechem, Stephen Rusckowski, Surya Mohapatra, Daniel Stanzione

Premium

NanoString Technologies has appointed Joseph Beechem as senior vice president of research and development.

Beechem joins the company from Life Technologies, where he was most recently vice president; head of advanced sequencing; and head of global sequencing chemistry, biochemistry, and biophysics. Prior to that, he was chief technology officer of Life Technologies, chief scientific officer at Invitrogen (now part of Life Tech), and director of biosciences at Molecular Probes. Prior to joining industry, Beechem was an associate professor at Vanderbilt University for 11 years.



Quest Diagnostics
has named Stephen Rusckowski as president and CEO, succeeding Surya Mohapatra. He will also become a member of the board of directors.

Rusckowski is currently CEO of Philips Healthcare. Before that he held a variety of management positions in the healthcare division of Hewlett-Packard/Agilent Technologies.

Quest also announced that Daniel Stanzione will become non-executive chairman of the board.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.